1. |
Lee JS, Adrie C, Jacob HJ, et al. Chronic inhalation of nitric oxide inhibits neointimal formation after ballooninduced arterial injury [J]. Circ Res, 1996; 78(2)∶337.
|
2. |
Nikol S, Huehns TY, Krausz E, et al. Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation [J]. Gene Ther, 1999; 6(5)∶737.
|
3. |
Kibbe MR, Nie S, Yoneyama T, et al. Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein grafts [J]. Surgery, 1999; 126(2)∶323.
|
4. |
Dichek DA, Anderson J, Kelly AB, et al. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors [J]. Circulation, 1996; 93(2)∶301.
|
5. |
Hanna AK, Fox JC, Neschis DG, et al. Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury [J].J Vasc Surg, 1997; 25(2)∶320.
|
6. |
Cioffi CL, Garay M, Johnston JF, et al. Selective inhibition of ARaf and CRaf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of ARaf and CRaf in seruminduced proliferation [J].Mol Pharmacol, 1997; 51(3)∶383.
|
7. |
von der Leyen HE, Dzau VJ. Therapeutic potential of nitric oxide synthase gene manipulation [J].Circulation, 2001; 103(22)∶2760.
|
8. |
Chen L, Daum G, Forough R, et al. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in ballooninjured carotid artery [J].Circ Res, 1998; 82(8)∶862.
|
9. |
Zoldhelyi P, McNatt J, Xu XM,et al. Prevention of arterial thrombosis by adenovirusmediated transfer of cyclooxygenase gene [J]. Circulation, 1996; 93(1)∶10.
|
10. |
Stark VK, Hoch JR, Warner TF, et al. Monocyte chemotactic protein1 expression is associated with the development of vein graft intimal hyperplasia [J]. Arterioscler Thromb Vasc Biol, 1997; 17(8)∶1614.
|
11. |
李福生,王宗立,许漫,等. 表达反义单核细胞趋化蛋白1重组逆转录病毒对家兔动脉平滑肌单核细胞趋化蛋白1基因表达的影响 [J]. 中国动脉硬化杂志, 1999; 7(4)∶283.
|
12. |
Ueno H, Yamamoto H, Ito S, et al. Adenovirusmediated transfer of a dominantnegative Hras suppresses neointimal formation in ballooninjured arteries in vivo [J]. Arterioscler Thromb Vasc Biol, 1997; 17(5)∶898.
|
13. |
Gunn J, Holt CM, Francis SE, et al. The effect of oligonucleotides to cmyb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty [J]. Circ Res, 1997; 80(4)∶520.
|
14. |
Chen SJ, Chen YF, Miller DM, et al. Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo [J]. Circulation, 1994; 90(5)∶2468.
|
15. |
Qian HS, Channon K, Neplioueva V, et al. Improved adenoviral vector for vascular gene therapy: beneficial effects on vascular function and inflammation [J]. Circ Res, 2001; 88(9)∶911.
|
16. |
Chang MW, Barr E, Lu MM, et al. Adenovirusmediated overexpression of the cyclin/cyclindependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty [J]. J Clin Invest, 1995; 96(5)∶2260.
|
17. |
Luo Z, Sata M, Nguyen T, et al. Adenovirusmediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals [J]. Circulation, 1999; 99(14)∶1776.
|
18. |
Chen D, Krasinski K, Sylvester A, et al. Downregulation of cyclindependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery [J]. J Clin Invest, 1997; 99(10)∶2334.
|
19. |
Yonemitsu Y, Kaneda Y, Tanaka S, et al. Transfer of wildtype p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo [J]. Circ Res, 1998; 82(2)∶147.
|
20. |
Scheinman M, Ascher E, Kallakuri S, et al. P53 gene transfer to the injured rat carotid artery promotes apoptosis [J]. Surgery, 1999; 126(5)∶863.
|
21. |
Autieri MV. Expression of anaphasepromoting complex 5 in balloon angioplastyinjured rat carotid arteries and mitogenstimulated human vascular smooth muscle cells [J]. Biochem Biophys Res Commun, 2001; 282(3)∶723.
|
22. |
Maillard L, Van Belle E, Smith RC, et al. Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty [J]. Cardiovasc Res, 1997; 35(3)∶536.
|
23. |
Morishita R, Gibbons GH, Horiuchi M, et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo [J]. Proc Natl Acad Sci USA, 1995; 92(13)∶5855.
|
24. |
Nabel EG, Plautz G, Boyce FM, et al. Recombinant gene expression in vivo within endothelial cells of the arterial wall [J]. Science, 1989; 244(4910)∶1342.
|
25. |
Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury [J]. Science, 1994; 265(5173)∶781.
|
26. |
Guzman RJ, Hirschowitz EA, Brody SL, et al. In vivo suppression of injuryinduced vascular smooth muscle cell accumulation using adenovirusmediated transfer of the herpes simplex virus thymidine kinase gene [J]. Proc Natl Acad Sci USA, 1994; 91(22)∶10732.
|
27. |
乔正荣, 时德. 细胞凋亡和血管病变 [J]. 中国普外基础与临床杂志, 2001; 8(3)∶202.
|
28. |
George SJ, Johnson JL, Angelini GD, et al. Adenovirusmediated gene transfer of the human TIMP1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein [J]. Hum Gene Ther, 1998; 9(6)∶867.
|
29. |
Dollery CM, Humphries SE, McClelland A, et al. Expression of tissue inhibitior of matrix metalloproteinases 1 by use of an adenoviral vector inhibitors smooth muscle cell migration and reduces neointimal byperplasia in the rat model of vascular balloon injury [J]. Circulation, 1999; 99(24)∶3199.
|
30. |
涂兵, 金立人. 血管内皮细胞生长因子及有关肢体缺血基因治疗的研究进展 [J]. 中国普外基础与临床杂志, 2000; 7(3)∶202.
|
31. |
Van Belle E, Maillard L, Tio FO, et al. Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces instent intimal formation [J]. Biochem Biophys Res Commun, 1997; 235(2)∶311.
|